Similar articles

• 2,3-Diarylcyclopentenones as orally active, highly selective cyclooxygenase-2 inhibitors.

  Black WC, Brideau C, Chan CC, Charleson S, Chauret N, Claveau D, Ethier D, Gordon R, Greig G, Guay J, Hughes G, Jolicoeur P, Leblanc Y, Nicoll-Griffith D, Ouimet N, Riendeau D, Visco D, Wang Z, Xu L, Prasit P. Black WC, et al. J Med Chem. 1999 Apr 8;42(7):1274-81. doi: 10.1021/jm980642l. J Med Chem. 1999. PMID: 10197970
• Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: a novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach.

  Chan CC, Boyce S, Brideau C, Ford-Hutchinson AW, Gordon R, Guay D, Hill RG, Li CS, Mancini J, Penneton M, et al. Chan CC, et al. J Pharmacol Exp Ther. 1995 Sep;274(3):1531-7. J Pharmacol Exp Ther. 1995. PMID: 7562530
• From indomethacin to a selective COX-2 inhibitor. Development of indolalkanoic acids as potent and selective cyclooxygenase-2 inhibitors.

  Lau CK, Black WC, Belley M, Chan C, Charleson S, Denis D, Gauthier JY, Gordon R, Guay D, Hamel P, Kargman S, Leblanc Y, Mancini J, Ouellet M, Percival D, Prasit P, Roy P, Skorey K, Tagari P, Vickers P, Wong E. Lau CK, et al. Adv Exp Med Biol. 1997;407:73-8. Adv Exp Med Biol. 1997. PMID: 9321934 No abstract available.
• Synthesis and structure-activity relationship of a new series of COX-2 selective inhibitors: 1,5-diarylimidazoles.

  Almansa C, Alfón J, de Arriba AF, Cavalcanti FL, Escamilla I, Gómez LA, Miralles A, Soliva R, Bartrolí J, Carceller E, Merlos M, García-Rafanell J. Almansa C, et al. J Med Chem. 2003 Jul 31;46(16):3463-75. doi: 10.1021/jm030765s. J Med Chem. 2003. PMID: 12877584
• [Coxibs: highly selective cyclooxygenase-2 inhibitors. Part I. Clinical efficacy].

  Burdan F, Korobowicz A. Burdan F, et al. Pol Merkur Lekarski. 2003 Apr;14(82):348-51. Pol Merkur Lekarski. 2003. PMID: 12868200 Review. Polish.